Sharon Stone on getting slapped by Gene Hackman, sparring with De Niro, and the biopic she's 'desperate' to make - Business Insider

Skip to Content Subscribe FAQ My Account Manage My Subscription News Local News Crime Politics True Crime National World Weather Archives Business Energy Local Business Real Estate First-Time Homebuyers Commercial Real Estate FP Markets FP Headlines FP Money Technology Gaming Science Space Small Business Alberta's Top Employers Sports Calgary Flames NHL PWHL More Hockey Calgary Stampeders CFL NFL Calgary Cavalry Calgary Roughnecks Spruce Meadows Soccer International Soccer MLS Baseball Basketball Golf Golf Videos Curling Rodeo-Chucks Tennis Auto Racing Opinion Columnists Letters Editorials Send us an Opinion Column or Letter Arts Local Arts Movies Movie Listings Television TV Listings Theatre Music Celebrity Books Life Health Women Men Sexual Health Diet & Fitness Family & Child Special Sections CALGARY HOME + GARDEN SHOW Encore Lifestyles CALGARY FALL HOME SHOW Food Homes New Homes Condos Rec Properties Calgary Homes & Design Fashion & Beauty Parenting Relationships Advice Horoscopes Royals Travel Ski & Snowboard Travel Alberta Travel Canada Travel USA Travel International Cruises Travel Essentials Savings Contests Readers' Choice Lives Told Tails Told Shopping Calgary Herald

AtlanticNova ScotiaNew BrunswickPrince Edward Island Newfoundland and LabradorCalgaryLethbridgeKitchenerGuelphNorthern OntarioSudburyNorth BaySault Ste. MarieTimminsOttawaKingstonBrockvillePembrokeReginaYorktonSaskatoonPrince AlbertTorontoWatchWeatherPeelHamiltonDurhamYorkHaltonNiagaraQueen's ParkToronto City HallIn PicturesVancouverVancouver IslandCanadaLocal SpotlightRoyal FamilyPoliticsNanosPower PlayQuestion PeriodFederal Election 2025WorldMideast ConflictRussia-Ukraine WarWatchLatestCaptured on CameraPoliticsLifestyleConsumerHealthExplainedEntertainmentTechnologyDeception DecodedAutosEnvironmentBusinessInflationReal EstateAutos

Severe sunburn increases the risk of developing melanoma, the most serious type of skin cancer. Credit: Olga Pankova/GettyA personalized mRNA vaccine reduced the risk of skin cancer returning or the recipient dying by 42% when used alongside an immunotherapy drug, according to long-awaited results for what could become the first approved mRNA vaccine for cancer. Oncologists regard a risk reduction of 10% as substantial, says Kristen Radford, an immunotherapist at Mater Research in Brisbane. A risk reduction of more than 40% “would send many researchers over the Moon”, adds Seth Cheetham, a geneticist at the University of Queensland in Brisbane, Australia. The personalized vaccine, called intismeran, is not designed to prevent skin cancer, or melanoma, from developing in the first place, but to stop it returning in people who have already undergone surgery to remove tumours. Anticipation for the trial results has been building since August, when the vaccine’s developers — Merck, based in Rahway, New Jersey, and Moderna, which is headquartered in Cambridge, Massachusetts — announced early positive results.